InvestorsHub Logo
Followers 5
Posts 282
Boards Moderated 0
Alias Born 10/09/2006

Re: None

Tuesday, 01/12/2010 3:58:30 PM

Tuesday, January 12, 2010 3:58:30 PM

Post# of 6386
Glycemic (i.e. blood sugar) levels are a “vital sign” for Diabetics and failure to accurately monitor them can results in a plethora of chronic health conditions. Did you know that someone dies from Diabetes-related complications every 10 seconds? How about that fact that the same number of people die annually from Diabetes as from HIV & AIDS?

Clearly, the need to improve quality of life for those afflicted is a MAJOR priority for the healthcare industry. This presents a prime opportunity for Echo Therapeutics to help improve life for millions of people just like the company's mentioned above.

The company's core focus – Glucose Control – is widely viewed as one of, if not the biggest, factors in reducing risk for sufferers. Aside from death, a Diabetic loses a leg every 30 seconds somewhere in the world and 85% of these amputations could be prevented through improved care, part of which includes tighter glycemic control.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.